Osteologie 2022; 31(03): 203
DOI: 10.1055/s-0042-1755912
DOI: 10.1055/s-0042-1755912
Abstracts
Vorträge
Changes in dispensing of anti-osteoporotic drugs during COVID-19 pandemic
Authors
-
Theresa Stockinger
1 Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA, Sigmund Freud University, School of medicine, Metabolic bone diseases, 1st Med. Department, Wien -
Martina Behanova
2 Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, Wien -
Berthold Reichardt
3 Austrian Social Health Insurance Fund, Österreichische Gesundheitskasse, Eisenstadt -
Judith Haschka
4 Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Med. Department, Wien -
Heinrich Resch
5 St. Vincent Hospital Vienna , Sigmund Freud University, School of medicine, Metabolic bone diseases, 2nd Department of Internal Medicine, Wien -
Jochen Zwerina
4 Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Med. Department, Wien -
Roland Kocijan
6 Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA, Trauma Centre Meidling, Sigmund Freud University, School of medicine, Metabolic bone diseases, 1st Med. Department, Wien

